Tarsus Pharmaceuticals, Inc.
SEC CIK 1819790 · TARS · last insider filing 2026-06-29
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Pyott David E I | Director | filed 2026 - 2026 |
| Yarno Wendy L | Director | filed 2020 - 2026 |
| Link William J PHD | Director | filed 2020 - 2026 |
| Chaudhuri Bhaskar | Director | filed 2020 - 2026 |
| Morrison Scott W | Director | filed 2022 - 2026 |
| Goldberg Andrew D. | Director | filed 2020 - 2026 |
| Goodrich Katherine | Director | filed 2024 - 2026 |
| Azamian Bobak R. | Director · President/CEO and Board Chair | filed 2020 - 2026 |
| Lin Elizabeth Yeu | Director · Chief Medical Officer | filed 2022 - 2026 |
| Crane Rosemary A | Director | filed 2021 - 2024 |
| Ackermann Michael | Director | filed 2020 - 2022 |
| Tester Jason E. | Director | filed 2020 - 2021 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Farrow Jeffrey S | See Remarks | filed 2023 - 2026 |
| Neervannan Seshadri | Chief Operating Officer | filed 2020 - 2026 |
| Mottiwala Aziz | Chief Commercial Officer | filed 2020 - 2026 |
| Whitfield Dianne C. | Chief Human Resources Officer | filed 2021 - 2026 |
| Wahl Bryan | General Counsel | filed 2021 - 2026 |
| Trevejo Jose M. | Chief Medical Officer | filed 2022 - 2023 |
| Greenstein Leonard M. | Chief Financial Officer | filed 2020 - 2023 |
| Holdbrook Mark J. | V.P., Clinical Affairs | filed 2020 - 2023 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.